(Approved in the US, Canada and Latin America) – This Nicotine Transdermal System delivers 21mg, 14mg and 7mg respectively of nicotine over a 24 hour period. Indicated for smoking cessation, it reduces withdrawal symptoms, including nicotine cravings associated with quitting smoking.
Please contact us for more information.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.